Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.59

-0.9%

Oct 30 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom rusnak who wrote (1437)	6/17/2003 2:39:06 AM
From: Icebrg	Read Replies (1) of 1475

Clearly there are values left in the company. The question is how much and whether they will be able to conserve it. They own a third of Immerge, and some (for me unknown) equity position in an Australian stem cell company. They have some rights (for the time being) to MEDI-507. They have rights to what the call their allomune system, which doesn't seem to move but appears to be useful. Rick? And they have some cash. It is doubtful though what will happen when the current j/v period for Immerge runs out (towards the end of the year). Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next